Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
5.11
+0.70 (15.87%)
At close: Mar 9, 2026, 4:00 PM EDT
5.10
-0.01 (-0.20%)
After-hours: Mar 9, 2026, 7:52 PM EDT
Rocket Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 77.56 | 163.64 | 55.9 | 140.52 | 232.69 | Upgrade
|
| Short-Term Investments | 111.37 | 208.7 | 317.27 | 215.88 | 156.05 | Upgrade
|
| Cash & Short-Term Investments | 188.93 | 372.34 | 373.18 | 356.39 | 388.74 | Upgrade
|
| Cash Growth | -49.26% | -0.22% | 4.71% | -8.32% | -19.47% | Upgrade
|
| Prepaid Expenses | 3.81 | 5.85 | 5.05 | 7.67 | 3.32 | Upgrade
|
| Total Current Assets | 192.73 | 378.18 | 378.22 | 364.06 | 392.06 | Upgrade
|
| Property, Plant & Equipment | 71.59 | 83.32 | 87.59 | 77.65 | 72.35 | Upgrade
|
| Long-Term Investments | - | - | 34.32 | 43.28 | - | Upgrade
|
| Goodwill | 39.15 | 39.15 | 39.15 | 39.15 | 30.82 | Upgrade
|
| Other Intangible Assets | 25.15 | 25.15 | 25.15 | 25.72 | - | Upgrade
|
| Other Long-Term Assets | 1.82 | 1.89 | 1.91 | 1.95 | 1.8 | Upgrade
|
| Total Assets | 330.45 | 527.7 | 566.34 | 551.81 | 497.02 | Upgrade
|
| Accounts Payable | 2.33 | 1.63 | 1.77 | 2.27 | 0.48 | Upgrade
|
| Accrued Expenses | 24.91 | 36.02 | 29.8 | 30.54 | 17.81 | Upgrade
|
| Current Portion of Leases | 2.92 | 2.86 | 2.72 | 2.51 | 2.55 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.6 | 0.6 | Upgrade
|
| Other Current Liabilities | 0.05 | 0.19 | 14.21 | 3.25 | 0.73 | Upgrade
|
| Total Current Liabilities | 30.21 | 40.68 | 48.51 | 39.17 | 22.17 | Upgrade
|
| Long-Term Leases | 21.96 | 22.64 | 22.33 | 20.36 | 20.05 | Upgrade
|
| Other Long-Term Liabilities | 1.06 | 1.14 | 2.94 | 2.6 | 0.08 | Upgrade
|
| Total Liabilities | 53.23 | 64.47 | 73.77 | 62.12 | 42.3 | Upgrade
|
| Common Stock | 1.08 | 1.07 | 0.9 | 0.79 | 0.65 | Upgrade
|
| Additional Paid-In Capital | 1,717 | 1,680 | 1,451 | 1,203 | 946.15 | Upgrade
|
| Retained Earnings | -1,441 | -1,218 | -959.37 | -713.78 | -491.91 | Upgrade
|
| Treasury Stock | - | - | - | -0.05 | - | Upgrade
|
| Comprehensive Income & Other | -0.03 | 0.07 | 0.32 | -0.36 | -0.16 | Upgrade
|
| Total Common Equity | 277.22 | 463.23 | 492.57 | 489.69 | 454.72 | Upgrade
|
| Shareholders' Equity | 277.22 | 463.23 | 492.57 | 489.69 | 454.72 | Upgrade
|
| Total Liabilities & Equity | 330.45 | 527.7 | 566.34 | 551.81 | 497.02 | Upgrade
|
| Total Debt | 24.88 | 25.5 | 25.04 | 22.87 | 22.6 | Upgrade
|
| Net Cash (Debt) | 164.05 | 346.84 | 348.13 | 333.53 | 366.14 | Upgrade
|
| Net Cash Growth | -52.70% | -0.37% | 4.38% | -8.91% | -13.04% | Upgrade
|
| Net Cash Per Share | 1.48 | 3.66 | 4.14 | 4.89 | 5.79 | Upgrade
|
| Filing Date Shares Outstanding | 108.57 | 106.63 | 90.5 | 79.35 | 64.51 | Upgrade
|
| Total Common Shares Outstanding | 108.32 | 106.45 | 90.28 | 79.12 | 64.51 | Upgrade
|
| Working Capital | 162.53 | 337.5 | 329.72 | 324.89 | 369.89 | Upgrade
|
| Book Value Per Share | 2.56 | 4.35 | 5.46 | 6.19 | 7.05 | Upgrade
|
| Tangible Book Value | 212.92 | 398.93 | 428.27 | 424.81 | 423.91 | Upgrade
|
| Tangible Book Value Per Share | 1.97 | 3.75 | 4.74 | 5.37 | 6.57 | Upgrade
|
| Machinery | 48.06 | 48.85 | 44.58 | 35.61 | 25.21 | Upgrade
|
| Leasehold Improvements | 7.33 | 7.28 | 6.72 | 0.59 | 0.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.